Dongsheng Wang

Dongsheng Wang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
WCWen-Bo Cui
Wen-Bo Cui
ZZZong-Ping Zhang
Zong-Ping Zhang
XBXue Bai
Xue Bai
SWShanshan Wang
Shanshan Wang
XCXiao-Han Chen
Xiao-Han Chen
DWDongsheng Wang
Dongsheng Wang
Alzheimer’s disease (AD) is one of the leading causes of dementia. As the first common neurodegenerative disease, there are no effective drugs that can reverse the progression. The present study is to report the anti-AD effect of cryptotanshinone (CTS), a natural product isolated from Salvia castanea. It is found that it can alleviate AD-like features associated with Aβ1-42 toxicity in muscle cells as well as neuronal cells of Caenorhabditis elegans (C. elegans). Further studies showed that CTS reduced the level of reactive oxygen species (ROS) in nematodes, up-regulated the expression of sod-3, and enhanced superoxide dismutase activity. Cryptotanshinone reduced the level of Aβ monomers and highly toxic oligomers in C. elegans while inhibiting the abnormal aggregation of polyglutamine protein. In addition, CTS upregulated the expression of hsp-16.2 and downregulated the expression of ace-2. These results suggested that CTS could alleviate oxidative stress and reduce the level of abnormally aggregated proteins and has the potential to be developed as an anti-AD drug candidate.

15 July 2021 in Nutritional Neuroscience
Verified
Journal Article
Closed access
DZDejuan Zhi
Dejuan Zhi
WYWenqi Yang
Wenqi Yang
JYJuan Yue
Juan Yue
SXShuaishuai Xu
Shuaishuai Xu
WMWenjuan Ma
Wenjuan Ma
DWDongsheng Wang
Dongsheng Wang
There are few effective medications to treat Alzheimer’s disease (AD). It has been suggested that several ginsenosides possess mild or moderate anti-AD activity. In our present work, a preferred combined ginsenosides was shown to have a more significant benefit effect on AD-like symptoms of worm paralysis and hypersensitivity to exogenous 5-HT in C. elegans. The combined ginsenosides can suppress Aβ deposits and Aβ oligomers, alleviating the toxicity induced by Aβ overexpression more effectively than used alone. Its anti-AD effect was partially abolished by hsf-1 RNAi knocked down or hsf-1 inactivation by point mutation, but not by daf-16 or skn-1 RNAi knocked down. Furthermore, it markedly activated hsp-16.2 gene expression downstream of HSF-1. Our results demonstrated that HSF-1 signaling pathway exerts an important role in mediating the therapeutic effect of combined ginsenosides on AD worms. These results provided powerful evidences and theoretical foundation for reshaping medicinal products of ginsenosides and ginseng on prevention of neurodegenerative diseases.

Verified
Journal Article
Open access
PDF file
ZZZong-Ping Zhang
Zong-Ping Zhang
XBXue Bai
Xue Bai
WCWen-Bo Cui
Wen-Bo Cui
XCXiao-Han Chen
Xiao-Han Chen
XLXu Liu
Xu Liu
DWDongsheng Wang
Dongsheng Wang
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease in the world. However, there is no effective drug to cure it. Caesalmin C is a cassane-type diterpenoid abundant in Caesalpinia bonduc (Linn.) Roxb. In this study, we investigated the effect of caesalmin C on Aβ-induced toxicity and possible mechanisms in the transgenic Caenorhabditis elegans AD model. Our results showed that caesalmin C significantly alleviated the Aβ-induced paralysis phenotype in transgenic CL4176 strain C. elegans. Caesalmin C dramatically reduced the content of Aβ monomers, oligomers, and deposited spots in AD C. elegans. In addition, mRNA levels of sod-3, gst-4, and rpt-3 were up-regulated, and mRNA levels of ace-1 were down-regulated in nematodes treated with caesalmin C. The results of the RNAi assay showed that the inhibitory effect of caesalmin C on the nematode paralysis phenotype required the DAF-16 signaling pathway, but not SKN-1 and HSF-1. Further evidence suggested that caesalmin C may also have the effect of inhibiting acetylcholinesterase (AchE) and upregulating proteasome activity. These findings suggest that caesalmin C delays the progression of AD in C. elegans via the DAF-16 signaling pathway and that it could be developed into a promising medication to treat AD.

11 July 2023 in Bioorganic Chemistry
Verified
Journal Article
Closed access
XBXue Bai
Xue Bai
CLChun-Min Liu
Chun-Min Liu
HLHui-Jie Li
Hui-Jie Li
ZZZong-Ping Zhang
Zong-Ping Zhang
WCWen-Bo Cui
Wen-Bo Cui
DFDong-Qing Fei
Dong-Qing Fei

6 June 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
DZDejuan Zhi
Dejuan Zhi
SXShuaishuai Xu
Shuaishuai Xu
LZLing Zhang
Ling Zhang
YLYuxuan Li
Yuxuan Li
HZHai Zhu
Hai Zhu
DWDongsheng Wang
Dongsheng Wang

6 May 2025 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
CZChengmu Zhao
Chengmu Zhao
JYJuan Yue
Juan Yue
YXYu Xie
Yu Xie
BLBo Liu
Bo Liu
SXShuaishuai Xu
Shuaishuai Xu
DWDongsheng Wang
Dongsheng Wang